Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProSPAR: Progesterone for HIV-positive pregnant women on cART
NCT02400021Phase 2Unknown
- Sponsor
- Mount Sinai Hospital
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of progesterone in preterm birth and low birth weight (LBW), sponsored by Mount Sinai Hospital. Primary endpoint: Total enrollment / eligible population per year at 12 months. Status: unknown.
02
Drugs
progesterone
03
Conditions
preterm birthlow birth weight (LBW)
Beyond the preview
Go deeper on NCT02400021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400021.